Skip to main content
G

Graftable

Graftable develops technology to accelerate the healing of wounds and soft tissue trauma, resulting in less scarring and tissue loss. This platform aims to improve functional and cosmetic outcomes following injury or surgical resection. The technology also supports the reliable transplantation of metabolically-demanding cell types and bioengineered tissues.

Philadelphia, United StatesFounded 2022150+ followers
Updated 20 months ago

Funding

$5K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

S
Funding rounds are not available yet.

Founders

Product

Problem

Skin and soft tissue injuries often heal slowly, resulting in significant scarring, tissue loss, and suboptimal functional and cosmetic outcomes for patients. Current treatments may not adequately address the complex regenerative processes required for complete tissue restoration, particularly in cases of disfiguring injuries or extensive tissue damage.

Solution

Graftable Bio is developing a therapeutic technology designed to accelerate the natural healing processes in skin and soft tissue injuries, promoting regeneration and minimizing scarring. Their approach aims to improve the long-term function and appearance of damaged tissues following injury, trauma, or surgery. By enhancing tissue regeneration, Graftable Bio's technology seeks to provide better cosmetic outcomes and reduce tissue loss for individuals who have experienced disfiguring injuries or cancer resections. Furthermore, the technology may facilitate the reliable transplantation and implantation of metabolically-demanding cell types, such as fat, pancreatic islet cells, or bioengineered tissues, by creating a more supportive environment for cell survival and integration.

Target Audience

The primary target audience includes patients with skin and soft tissue injuries resulting from trauma, surgery, or cancer resections, as well as clinicians and researchers involved in regenerative medicine and tissue transplantation.

Features

  • Accelerated healing of wounds and soft tissue trauma.
  • Reduced scarring and tissue loss during the healing process.
  • Enhanced regeneration of damaged skin and soft tissues.
  • Improved functional and cosmetic outcomes after injury or surgery.
  • Potential to enable reliable transplantation of metabolically-demanding cell types.
This profile is AI-generated and may contain inaccuracies.